Connection
Scott Cramer to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Scott Cramer has written about Antineoplastic Combined Chemotherapy Protocols.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.480 |
|
|
|
-
Schlaepfer IR, Rider L, Rodrigues LU, Gij?n MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glod? LM, Eckel RH, Cramer SD. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol Cancer Ther. 2014 Oct; 13(10):2361-71.
Score: 0.271
-
Axanova LS, Chen YQ, McCoy T, Sui G, Cramer SD. 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. Prostate. 2010 Nov 01; 70(15):1658-71.
Score: 0.209